Joseph Truitt

Joseph Truitt is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Chief Executive Officer of iECURE Inc. since March 2021, Truitt also holds positions as a Member of the Board of Trustees at La Salle University and as a Board Member at Code BioTherapeutics. Additional leadership roles include Chairman of the Board at Larimar Therapeutics Inc. and a prior tenure as Chief Executive Officer at BioSpecifics Technologies Corp. and Achillion Pharmaceuticals, where responsibilities encompassed global commercial planning, corporate strategy, and business development. Education includes an MBA in Pharmaceutical Marketing from Saint Joseph's University and a BS in Marketing from La Salle University.